What Researchers Did
Researchers developed and tested a new screening tool called the Carbon Monoxide Neuropsychological Screening Battery (CONSB) to better assess brain function in patients with carbon monoxide poisoning in emergency situations.
What They Found
The CONSB was administered to 66 patients poisoned by carbon monoxide and 66 healthy volunteers. The study found significant differences in performance between these two groups. This led to the conclusion that the CONSB improved the accuracy of evaluating brain-impaired patients with carbon monoxide poisoning.
What This Means for Canadian Patients
For Canadian patients exposed to carbon monoxide, this research highlights the importance of thorough neurological assessment beyond traditional methods. Using tools like the CONSB could help identify those who need aggressive oxygen therapy, including hyperbaric oxygen therapy, to prevent serious long-term brain damage.
Canadian Relevance
Covers a Health Canada-recognised indication: carbon monoxide poisoning.
Study Limitations
This study was published in 1991, so the screening battery and assessment methods may have evolved significantly since its publication.